Core Viewpoint - Shanxi Province is implementing several measures to promote high-quality development in the pharmaceutical and medical device industry through technological innovation and regulatory reforms [1] Group 1: Measures for Technological Innovation - The Shanxi Provincial Science and Technology Department has introduced six specific measures to support the research and innovation of pharmaceuticals and medical devices, including strengthening core technology research and accelerating drug development [1][2] - A total of 63 major special projects and key research plans have been initiated to address critical technology issues, with over 90 research platforms established to enhance collaborative innovation [2] Group 2: Talent and Funding Support - The Shanxi Provincial Science and Technology Department has recognized several innovative talent teams and appointed technology deputies to medical enterprises, providing essential talent support for core technology breakthroughs [2] - The government has allocated 69.11 million yuan in guiding funds, which has leveraged an additional 243.71 million yuan from social funds for technological innovation [2] Group 3: Innovation Incentives - A technology award subsidy program has been established to reward organizations and individuals contributing to technological innovation in the province [3] - High-tech enterprises that pass the recognition for the first time receive a reward of 100,000 yuan, while those that pass twice receive 200,000 yuan, reinforcing their role as innovation leaders [3]
山西6项举措促药品医疗器械技术攻关
Ke Ji Ri Bao·2025-07-03 01:10